Moderna is the second vaccine maker to seek full approval from U.S. regulators, which would allow it to market the shot directly to consumers. Full approval also makes it easier for schools, employers and the military to require inoculation against COVID-19. More than 100 million of the shots have already been administered, according to data compiled by the Centers for Disease Control and Prevention. Read more.
